Literature DB >> 11352909

Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain.

K Kawakami1, F Takeshita, R K Puri.   

Abstract

Interleukin (IL)-13 receptor alpha2 (IL-13Ralpha2) chain is an essential binding component for IL-13-mediated ligand binding. Recently, we have demonstrated that this receptor chain also plays an important role in the internalization of IL-13. To study the mechanism of IL-13 internalization, we generated mutated IL-13Ralpha2 chains that targeted trileucine residues (Leu(335), Leu(336), and Leu(337)) in the transmembrane domain and a tyrosine motif (Tyr(343)) in the intracellular domain and transfected these cDNAs in COS-7 cells. Cells that expressed a C-terminally truncated IL-13Ralpha2 chain (Delta335) did not bind IL-13, suggesting that the trileucine region modulates IL-13 binding. Truncation of IL-13Ralpha2 chain with a mutation in the trileucine region resulted in significantly decreased internalization compared with wild type IL-13Ralpha2 chain transfected cells. COS-7 cells transfected with tyrosine motif mutants exhibited a similar internalization level compared with wild type IL-13Ralpha2 chain transfected cells; however, dissociation of cell surface IL-13 was faster compared with wild type IL-13Ralpha2 transfectants. These results were further confirmed by determining the cytotoxicity of a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin (IL13-PE38QQR) to cells that expressed IL-13Ralpha2 chain mutants. We further demonstrate that the IL-13Ralpha2 chain is not ubiquitinated and that internalization of IL-13Ralpha2 did not depend on ubiquitination. Together, our findings suggest that the dileucine motif in the trileucine region and tyrosine motif participate in IL-13Ralpha2 internalization in distinct manners.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352909     DOI: 10.1074/jbc.M100936200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  8 in total

1.  Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2.

Authors:  Patrick J Lupardus; Michael E Birnbaum; K Christopher Garcia
Journal:  Structure       Date:  2010-03-10       Impact factor: 5.006

2.  A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors.

Authors:  John Nemunaitis; Alex W Tong; Michael Nemunaitis; Neil Senzer; Anagha P Phadke; Cynthia Bedell; Ned Adams; Yu-An Zhang; Phillip B Maples; Salina Chen; Beena Pappen; James Burke; Daiju Ichimaru; Yasuo Urata; Toshiyoshi Fujiwara
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

3.  The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization.

Authors:  Madhu S Pandey; Edward N Harris; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

4.  A high-performance nanobio photocatalyst for targeted brain cancer therapy.

Authors:  Elena A Rozhkova; Ilya Ulasov; Barry Lai; Nada M Dimitrijevic; Maciej S Lesniak; Tijana Rajh
Journal:  Nano Lett       Date:  2009-09       Impact factor: 11.189

Review 5.  IL-13 receptor isoforms: breaking through the complexity.

Authors:  Yasuhiro Tabata; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

6.  A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects.

Authors:  M O'Toole; H Legault; R Ramsey; T A Wynn; M T Kasaian
Journal:  Clin Exp Allergy       Date:  2008-02-25       Impact factor: 5.018

7.  Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.

Authors:  Jing Han; Liming Yang; Raj K Puri
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.506

8.  In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.

Authors:  K Kawakami; M Kawakami; P J Snoy; S R Husain; R K Puri
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.